Cellid Co., Ltd.
Develops immunotherapeutic vaccines for cancer and infectious diseases.
299660 | KO
Overview
Corporate Details
- ISIN(s):
- KR7299660001
- LEI:
- Country:
- South Korea
- Address:
- 서울시 관악구 관악로 1 서울대학교 142동 5층, 서울시
- Website:
- http://www.cellid.co.kr
- Sector:
- Manufacturing
Description
Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-03-21 00:00 |
감사보고서제출
|
Korean | 18.5 KB | ||
| 2023-03-21 00:00 |
사업보고서 (2022.12)
|
Korean | 1.0 MB | ||
| 2023-03-20 00:00 |
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 9.9 KB | ||
| 2023-03-16 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 10.8 KB | ||
| 2023-03-14 00:00 |
주주총회소집공고
|
Korean | 412.1 KB | ||
| 2023-03-14 00:00 |
의결권대리행사권유참고서류
|
Korean | 394.9 KB | ||
| 2023-02-23 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2023-02-23 00:00 |
파생상품거래손실발생
|
Korean | 6.2 KB | ||
| 2023-02-23 00:00 |
주주총회소집결의
|
Korean | 15.4 KB | ||
| 2023-02-23 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.1 KB | ||
| 2023-02-17 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 86.1 KB | ||
| 2022-12-23 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 22.8 KB | ||
| 2022-12-23 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 24.9 KB | ||
| 2022-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2022-12-09 00:00 |
투자판단관련주요경영사항(COVID-19 예방 백신 AdCLD-CoV19-1의 제2b상 임상시험 조기종료 보고)
|
Korean | 10.7 KB |
Automate Your Workflow. Get a real-time feed of all Cellid Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cellid Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cellid Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
